Virtual ward: The future in the management of neutropenic sepsis in the NHS
Main Article Content
Abstract
Abstract
Virtual ward offers patients with neutropenic sepsis a unique opportunity to receive hospital level of care in the comfort of their home, especially for patients who would otherwise be admitted to hospital because of their acute treatment. On the virtual ward, patients can receive hospital level of care with a significant opportunity to mitigate any risk of hospital-acquired infection in this subset of patients who are already immunocompromised amongst other benefits. Additionally, hospital length of stay can be shortened leading to reduced admission pressure in hospitals, increasing hospital admission avoidance, and encouraging safe discharge from hospital while still providing the best care for the patients. We report a case of a 76-year-old cancer patient who presented with neutropenic sepsis and was successfully managed on the virtual ward in a district hospital. This case highlights the importance of virtual wards an evolving innovation that can define the future management of cancer patients in NHS. It is safe and reduces the cost of inpatient care in healthcare.
Downloads
Article Details
Copyright (c) 2024 Taiwo DD, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
|
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
|
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
Overview: Neutropenic sepsis: prevention and management in people with cancer: Guidance. NICE. The National Institute for Health and Care Excellence (2012) https://www.nice.org.uk/guidance/cg151.
Knight T, Ahn S, Rice TW, Cooksley T. Acute Oncology Care: A narrative review of the acute management of neutropenic sepsis and immune-related toxicities of checkpoint inhibitors. Eur J Intern Med. 2017 Nov;45:59-65. doi: 10.1016/j.ejim.2017.09.025. Epub 2017 Oct 6. PMID: 28993098.
Gudiol C, Albasanz-Puig A, Cuervo G, Carratalà J. Understanding and Managing Sepsis in Patients With Cancer in the Era of Antimicrobial Resistance. Front Med (Lausanne). 2021 Mar 31;8:636547. doi: 10.3389/fmed.2021.636547. PMID: 33869250; PMCID: PMC8044357.
Skoetz N, Bohlius J, Engert A, Monsef I, Blank O, Vehreschild JJ. Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy. Cochrane Database Syst Rev. 2015 Dec 21;2015(12):CD007107. doi: 10.1002/14651858.CD007107.pub3. PMID: 26687844; PMCID: PMC7389519.
Clarke R T. Neutropenic sepsis: management and complications. Clinical Medicine. 2013; 13: 185-187. https://doi.org/10.7861/clinmedicine.13-2-185.
Lima SSS. Neutropenic patients and their infectious complications at a University Hospital. Revista Brasileira de Hematologia e Hemoterapia. 2013; 35: 18-22. https://doi.org/10.5581/1516-8484.20130009.
Al-Shamsi HO, Alhazzani W, Alhuraiji A, Coomes EA, Chemaly RF, Almuhanna M, Wolff RA, Ibrahim NK, Chua MLK, Hotte SJ, Meyers BM, Elfiki T, Curigliano G, Eng C, Grothey A, Xie C. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. Oncologist. 2020 Jun;25(6):e936-e945. doi: 10.1634/theoncologist.2020-0213. Epub 2020 Apr 27. PMID: 32243668; PMCID: PMC7288661.
Singh N, Singh Lubana S, Dabrowski L. Isolated Chronic and Transient Neutropenia. Cureus. 2019 Sep 10;11(9):e5616. doi: 10.7759/cureus.5616. PMID: 31720132; PMCID: PMC6823038.
Murakami Y, Shindo Y, Sano M, Okumura J, Kobayashi H, Sakakibara T, Iguchi M, Takahashi K, Yagi T, Matsui S, Hasegawa Y. Effects of lymphocyte and neutrophil counts and their time courses on mortality in patients with postoperative pneumonia. Sci Rep. 2022 Aug 26;12(1):14564. doi: 10.1038/s41598-022-18794-5. PMID: 36028549; PMCID: PMC9411836.
The UK Sepsis Trust Home Page. What is Sepsis? Sepsis Symptoms, sepsistrust.org/wp-content/uploads/2018/06/Sepsis_Manual_2017_web_download.pdf.
Kim SM, Kim YJ, Kim YJ, Kim WY. Prognostic Impact of Neutropenia in Cancer Patients with Septic Shock: A 2009-2017 Nationwide Cohort Study. Cancers (Basel). 2022 Jul 24;14(15):3601. doi: 10.3390/cancers14153601. PMID: 35892860; PMCID: PMC9332608.
Forcano-Queralt E, Lemes-Quintana C, Orozco-Beltrán D. Ambulatory management of low-risk febrile neutropenia in adult oncological patients. Systematic review. Support Care Cancer. 2023 Nov 3;31(12):665. doi: 10.1007/s00520-023-08065-y. PMID: 37921996; PMCID: PMC10624743.
NHS England World-leading NHS virtual wards treat 100,000 patients in a year. NHS England, www.england.nhs.uk/2023/03/world-leading-nhs-virtual-wards-treat-100000-patients-in-a-year.
Virtual wards enabled by technology: Guidance on selecting and procuring a technology platform. NHS Transformation Directorate, (2023) transform.england.nhs.uk/covid-19-response/technology-nhs/virtual-wards-enabled-by-technology-guidance-on-selecting-and-procuring-a-technology-platform.
How to scale up delivery of virtual wards to ease pressure on the NHS. Public Sector Focus (NHS Providers) (2023) https://flickread.com/edition/html/index.php?pdf=6538e23f7270c#20